Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Objective: The aim was to formulate practice guidelines for endocrine evaluation and treatment of pituitary incidentalomas. Consensus Process: Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails and one in-person meeting. Conclusions: We recommend that patients with a pituitary incidentaloma undergo a complete history and physical examination, laboratory evaluations screening for hormone hypersecretion and for hypopituitarism, and a visual field examination if the lesion abuts the optic nerves or chiasm. We recommend that patients with incidentalomas not meeting criteria for surgical removal be followed with clinical assessments, neuroimaging (magnetic resonance imaging at 6 months for macroincidentalomas, 1 yr for a microincidentaloma, and thereafter progressively less frequently if unchanged in size), visual field examinations for incidentalomas that abut or compress the optic nerve and chiasm (6 months and yearly), and endocrine testing for macroincidentalomas (6 months and yearly) after the initial evaluations. We recommend that patients with a pituitary incidentaloma be referred for surgery if they have a visual field deficit; signs of compression by the tumor leading to other visual abnormalities, such as ophthalmoplegia, or neurological compromise due to compression by the lesion; a lesion abutting the optic nerves or chiasm; pituitary apoplexy with visual disturbance; or if the incidentaloma is a hypersecreting tumor other than a prolactinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“The GRADE group is an international group with expertise in development and implementation of evidence-based guidelines (1).”
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 3×
“• Hypersecreting tumors other than prolactinomas as recommended by other guidelines of The Endocrine Society and The Pituitary Society.”
BackgroundInfluentialSelf-citationFernandez, A., Karavitaki, N., & Wass, J. A. H. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03667.x · Cited by 1,115
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Self-citationHigh Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, Belgium
Daly, A. F., Rixhon, M., Adam, C., Dempegioti, A., Tichomirowa, M. A., & Beckers, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1668 · Cited by 1,025
Self-citationGuidelines of the Pituitary Society for the diagnosis and management of prolactinomas
Casanueva, F. F., Molitch, M. E., Schlechte, J. A., Abs, R., Bonert, V., Bronstein, M. D., Brue, T., Cappabianca, P., Colao, A., Fahlbusch, R., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02562.x · Cited by 829
Self-citationHall, W. A., Luciano, M. G., Doppman, J. L., Patronas, N. J., & Oldfield, E. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00001 · Cited by 627
Chatzellis, E., Alexandraki, K. I., Androulakis, I. I., & Kaltsas, G. (2015) · Neuroendocrinology · doi:10.1159/000371806 · Cited by 572
Barker, F. G., Klibanski, A., & Swearingen, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030461 · Cited by 506
Incidence of Pituitary Adenomas in Northern Finland in 1992–2007
Raappana, A., Koivukangas, J., Ebeling, T., & Pirilä, T. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0537 · Cited by 470
Research works printed but not linked: 10
- Fernandez-Balsells, 2010, The natural history of pituitary incidentalomas: a systematic review and meta-analysis, J Clin Endocrinol Metab
- Freda, 1999, Differential diagnosis of sellar masses., Endocrinol Metab Clin North Am, 28, 81, 10.1016/S0889-8529(05)70058-X · doi:10.1016/s0889-8529(05)70058-x
- Black, 1987, Hormone production in clinically nonfunctioning pituitary adenomas., J Neurosurg, 66, 244, 10.3171/jns.1987.66.2.0244 · doi:10.3171/jns.1987.66.2.0244
- Esiri, 1983, Pituitary adenomas: immunohistology and ultrastructural analysis of 118 tumors., Acta Neuropathol, 62, 1, 10.1007/BF00684914 · doi:10.1007/bf00684914
- Al-Shraim, 2006, The 2004 World Health Organization classification of pituitary tumors: what is new?, Acta Neuropathol, 111, 1, 10.1007/s00401-005-1093-6 · doi:10.1007/s00401-005-1093-6
- Karavitaki, 2007, Silent corticotroph adenomas., Arq Bras Endocrinol Metabol, 51, 1314, 10.1590/S0004-27302007000800017 · doi:10.1590/s0004-27302007000800017
- Greenman, 2005, Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth., Clin Endocrinol (Oxf), 63, 39, 10.1111/j.1365-2265.2005.02295.x · doi:10.1111/j.1365-2265.2005.02295.x
- Lohmann, 2001, Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline., Pituitary, 4, 173, 10.1023/A:1015366923810 · doi:10.1023/a:1015366923810
- Merola, 1993, Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas., Horm Res, 40, 149, 10.1159/000183785 · doi:10.1159/000183785
- de Bruin, 1992, Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro., J Clin Endocrinol Metab, 75, 1310
Cited by
Diagnosis and Treatment of Pituitary Adenomas: A Review
Molitch, M. E. (2017) · JAMA · doi:10.1001/jama.2016.19699 · Cited by 933
Self-citationPituitary-Tumor Endocrinopathies
Melmed, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1810772 · Cited by 604
Pangenomic Classification of Pituitary Neuroendocrine Tumors
Neou, M., Villa, C., Armignacco, R., Jouinot, A., Raffin-Sanson, M.-L., Septier, A., Letourneur, F., Diry, S., Diedisheim, M., Izac, B., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.11.002 · Cited by 340
Prevalence and outcomes of incidental imaging findings: umbrella review
O’Sullivan, J. W., Muntinga, T., Grigg, S., & Ioannidis, J. P. A. (2018) · BMJ · doi:10.1136/bmj.k2387 · Cited by 339
The Epidemiology of Pituitary Adenomas
Daly, A. F., & Beckers, A. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.04.002 · Cited by 325
Self-citationEpidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas
Ntali, G., & Wass, J. A. (2018) · Pituitary · doi:10.1007/s11102-018-0869-3 · Cited by 285
The incidence rate of pituitary adenomas in western Sweden for the period 2001–2011
Tjörnstrand, A., Gunnarsson, K., Evert, M., Holmberg, E., Ragnarsson, O., Rosén, T., & Filipsson Nyström, H. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0144 · Cited by 272
Approach to the Patient: Diagnosis of Cushing Syndrome
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac492 · Cited by 91
Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review
Chiodini, I., Vainicher, C. E., Morelli, V, Palmieri, S., Cairoli, E., Salcuni, A. S., Copetti, M., & Scillitani, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0289 · Cited by 73
Hypopituitarism and Central Diabetes Insipidus
Devin, J. K. (2012) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2012.06.001 · Cited by 33
Mathioudakis, N., Thapa, S., Wand, G. S., & Salvatori, R. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04442.x · Cited by 30
Less known aspects of central hypothyroidism: Part 1- Acquired etiologies
Benvenga, S., Klose, M., Vita, R., & Feldt-Rasmussen, U. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.09.003 · Cited by 19
Metadata
- Authors
- Freda, P. U., Beckers, A. M., Katznelson, L., Molitch, M. E., Montori, V. M., Post, K. D., & Vance, M. L.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-04-01
- Volume
- 96
- Issue
- 4
- Pages
- 894-904
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2127738340
- Cited by
- 585
- References
- 42
- FWCI
- 21.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.